Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piper… Grant US-RE48890-E1 United States of America 11 Jan 2022
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piper… Grant US-10206914-B2 United States of America 19 Feb 2019
Class-and isoform-specific HDAC inhibitors and uses thereof Grant US-10059657-B2 United States of America 28 Aug 2018
Class- and isoform-specific HDAC inhibitors and uses thereof Grant US-9540317-B2 United States of America 10 Jan 2017
Class II human histone deacetylases, and uses related thereto Grant US-8895284-B2 United States of America 25 Nov 2014
Class- and isoform-specific HDAC inhibitors and uses thereof Grant US-8716344-B2 United States of America 06 May 2014
Class II human histone deacetylases, and uses related thereto Grant US-8435780-B2 United States of America 07 May 2013
Histone deacetylases, and uses related thereto Grant US-8426592-B2 United States of America 23 Apr 2013
Histone deacetylases, and uses related thereto Grant US-8399233-B2 United States of America 19 Mar 2013
Histone deacetylases, and uses related thereto Grant US-8362084-B2 United States of America 29 Jan 2013
Histone deacetylases, and uses related thereto Grant US-8329945-B2 United States of America 11 Dec 2012
Histone deacetylases, and uses related thereto Grant US-8329946-B2 United States of America 11 Dec 2012
Histone deacetylase and tubulin deacetylase inhibitors Grant US-8304451-B2 United States of America 06 Nov 2012
Treatment of protein degradation disorders Application EP-2491926-A1 European Patent Office 29 Aug 2012
Nucleic acids encoding class II human histone deacetylases, and uses related thereto Grant US-8076116-B2 United States of America 13 Dec 2011